Samir N. Khleif
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers 53
- CAR-T cell therapy research 21
- Immunology top 1%
- Immunotherapy and Immune Responses 54
- Immune Cell Function and Interaction 19
- Biological Psychiatry top 5%
- Tryptophan and brain disorders 7
- Cancer Research top 5%
- Otorhinolaryngology top 5%
-
- vaccines and immunoinformatics approaches 10
-
- Lung Cancer Treatments and Mutations 7
-
- Cancer Research and Treatments 7
- Co-authors
- Gregory A. OttersonMikayel MkrtichyanFrederic J. KayeRasha Abu EidJay A. BerzofskyAmy CoxonScott AntoniaSeema Gupta
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Journal of Clinical Oncology (22 papers)Nature Immunology (1 paper)
- Partner nations
- United StatesFranceItaly
In The Last Decade
Samir N. Khleif
112 papers receiving 4.6k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Oncology 3.0k
- Immunology 1.9k
- Biological Psychiatry 70
- Cancer Research 411
- Otorhinolaryngology 111
Countries citing papers authored by Samir N. Khleif
This map shows the geographic impact of Samir N. Khleif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samir N. Khleif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samir N. Khleif more than expected).
Fields of papers citing papers by Samir N. Khleif
This network shows the impact of papers produced by Samir N. Khleif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samir N. Khleif. The network helps show where Samir N. Khleif may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Samir N. Khleif, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2021 | 3 | |
| 4 | 2021 | 2 | |
| 5 | 2021 | 1 | |
| 6 | 2021 | 170 | |
| 7 | 2020 | 3 | |
| 8 | Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Studybreakdown → | 2020 | 224 |
| 9 | 2020 | 2 | |
| 10 | 2020 | 38 | |
| 11 | 2018 | 14 | |
| 12 | 2017 | 87 | |
| 13 | 2017 | 61 | |
| 14 | 2017 | 117 | |
| 15 | 2016 | 127 | |
| 16 | 2014 | 41 | |
| 17 | 2014 | 38 | |
| 18 | 2011 | 36 | |
| 19 | 1999 | 80 | |
| 20 | 1997 | 72 |
About Samir N. Khleif
Samir N. Khleif is a scholar working on Immunology, Biological Psychiatry and Oncology, having authored 114 papers that have together received 4.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (54 papers), Cancer Immunotherapy and Biomarkers (53 papers), CAR-T cell therapy research (21 papers), Immune Cell Function and Interaction (19 papers), vaccines and immunoinformatics approaches (10 papers), Lung Cancer Treatments and Mutations (7 papers), Cancer Research and Treatments (7 papers) and Tryptophan and brain disorders (7 papers). The work is most often cited by research in Oncology (3.0k citations), Immunology (1.9k citations) and Biological Psychiatry (70 citations). Samir N. Khleif has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Gregory A. Otterson, Mikayel Mkrtichyan, Frederic J. Kaye, Rasha Abu Eid, Jay A. Berzofsky, Amy Coxon, Scott Antonia, Seema Gupta, Neil H. Segal and Joseph R. Nevins. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Nature Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.